[HTML][HTML] The theranostic promise for Neuroendocrine Tumors in the late 2010s-Where do we stand, where do we go?
More than 25 years after the first peptide receptor radionuclide therapy (PRRT), the concept
of somatostatin receptor (SSTR)-directed imaging and therapy for neuroendocrine tumors (…
of somatostatin receptor (SSTR)-directed imaging and therapy for neuroendocrine tumors (…
[HTML][HTML] Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: A SEER database analysis, 1977-2016
M Liu, L Wei, W Liu, S Chen, M Guan, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
… used separately from neuroendocrine neoplasms and neuroendocrine neoplasms for the …
WHO classification of digestive tumors is the neuroendocrine tumor classification system (9)…
WHO classification of digestive tumors is the neuroendocrine tumor classification system (9)…
Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice
S Sheikhbahaei, MS Sadaghiani… - American Journal of …, 2021 - Am Roentgen Ray Soc
… Neuroendocrine tumors (NETs) are a heterogeneous group of tumors derived from
neuroendocrine cells in various organs [1]. NETs can occur in almost any organ, but NETs most …
neuroendocrine cells in various organs [1]. NETs can occur in almost any organ, but NETs most …
[HTML][HTML] Early diagnosis and treatment of myocardial neuroendocrine tumor metastasis: the cornerstone role of multimodality imaging
N Mikail, A Pisani, S El Hatimi, O Hentic… - Circulation …, 2021 - Am Heart Assoc
… carcinoid syndrome related to an ileal neuroendocrine tumor (NET). The patient underwent
successful surgical resection of the primary tumor. Histological study confirmed the diagnosis …
successful surgical resection of the primary tumor. Histological study confirmed the diagnosis …
Prognostic value of 18F-FDG PET/CT in a large cohort of patients with advanced metastatic neuroendocrine neoplasms treated with peptide receptor radionuclide …
J Zhang, Q Liu, A Singh, C Schuchardt… - Journal of Nuclear …, 2020 - Soc Nuclear Med
… -differentiated SSTR-positive neuroendocrine tumors (5) and is … treatment of
gastroenteropancreatic neuroendocrine tumors. … promise for neuroendocrine tumors in the late …
gastroenteropancreatic neuroendocrine tumors. … promise for neuroendocrine tumors in the late …
[HTML][HTML] Somatostatin and somatostatin receptors: from signaling to clinical applications in neuroendocrine neoplasms
MI del Olmo-Garcia, S Prado-Wohlwend, A Andres… - Biomedicines, 2021 - mdpi.com
… neuroendocrine tumors (NETs) subclassified as G1, G2 and G3 (according proliferative
index and mitotic rate) and poorly differentiated neuroendocrine … It keeps the neuroendocrine …
index and mitotic rate) and poorly differentiated neuroendocrine … It keeps the neuroendocrine …
Theranostics in Neuroendocrine Tumors
S Vallabhajosula - Molecular Imaging and Targeted Therapy …, 2023 - Springer
… Neuroendocrine neoplasms (NENs) are a heterogeneous group of epithelial neoplastic …
neuroendocrine tumors (NETs) to very aggressive poorly differentiated neuroendocrine …
neuroendocrine tumors (NETs) to very aggressive poorly differentiated neuroendocrine …
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors
S Partelli, L Landoni, V Andreasi, C Nessi, F Muffatti… - Surgery, 2020 - Elsevier
… surgery, which is usually slow and can occur late after initial surgery. In fact, the median …
for PanNET were first published in the early 2010s. Surprisingly, in patients who had undergone …
for PanNET were first published in the early 2010s. Surprisingly, in patients who had undergone …
KSNM60 in Nuclear Endocrinology: from the Beginning to the Future
… glands, pituitary gland, and neuroendocrine tumors (NETs). In … Since the late 1980s, it has
been used to diagnose NETs in … In the 2010s, many changes occurred in how NETs were …
been used to diagnose NETs in … In the 2010s, many changes occurred in how NETs were …
Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
S Adant, GM Shah, JM Beauregard - European journal of nuclear medicine …, 2020 - Springer
The incidence of neuroendocrine tumours (NETs) is increasing, but curative therapeutic
options are limited because diagnosis is often delayed until the tumour has metastasized. …
options are limited because diagnosis is often delayed until the tumour has metastasized. …
相关搜索
- pancreatic neuroendocrine tumors
- neuroendocrine tumors peptide receptor radionuclide therapy
- gastrointestinal neuroendocrine tumors
- neuroendocrine tumor patients
- gastroenteropancreatic neuroendocrine tumors
- neuroendocrine tumor metastasis
- theranostics in neuroendocrine tumors
- neuroendocrine tumors united states
- neuroendocrine tumors 18f fdg pet
- neuroendocrine tumors 177lu dotatate
- neuroendocrine tumors molecular imaging
- diagnosis and treatment of neuroendocrine tumors
- neuroendocrine tumor therapy
- targeted radionuclide therapy of neuroendocrine tumors
- patients with progressive metastatic neuroendocrine tumors
- theranostic promise late 2010s